Company intelligence / Profile preview

Preventice Solutions

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Preventice Solutions developed wearable cardiac monitoring devices integrated with cloud-based analysis platforms using AI algorithms for rhythm detection. The company achieved 30% net sales growth to $158 million in 2020 and had served over one million cardiac patients before being acquired by Boston Scientific in 2021.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Preventice Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Preventice Solutions.

Explore the full profile